NTRK Alterations in Pediatric High-Risk Malignancies Identified Through European Clinical Sequencing Programs Constitute Promising Drug Targets

Pfaff, E., Adam de Beaumais, T., Marchais, A., van Tilburg, C. M., Blattner-Johnson, M., Dirksen, U., … Vassal, G. (2021). NTRK Alterations in Pediatric High-Risk Malignancies Identified Through European Clinical Sequencing Programs Constitute Promising Drug Targets. JCO Precision Oncology, (5), 450–454. https://doi.org/10.1200/po.20.00417